bitop and A.Vogel extend their partnership and launch Ectoin® Allergy Nasal Spray in the Netherlands ® inhalation solution in the Ukraine.
bitop and A.Vogel extend their partnership and launch Ectoin® Allergy Nasal Spray in the Netherlands ® inhalation solution in the Ukraine.
Dortmund, March 02nd 2021
We are very happy to announce that our partner A.Vogel, based in Elburg, has launched Ectoin® Allergy Nasal Spray under the brand name Pollinosan® Hooikoorts Neusspray in the Netherlands.
The Ectoin® Allergy Nasal Spray is a globally successful product for treatment and prevention of allergic rhinitis symptoms. It protects against harmful influences of allergens and reduces allergen induced inflammations of the nasal mucosa. Containing the 100% natural ingredient Ectoin® the solution has clinically shown to be as effective as the pharmacological standard treatment Azelastine.*
A.Vogel develops and manufactures herbal medicines (phytopharmaceuticals), foods and supplements from fresh plants and distributes them internationally. Their products aim on supporting people to maintain or regain health in a natural way. In the Netherlands A.Vogel distributes their products through all commonly known retailers and therefore reaches a wide customer base.
“We are happy to satisfy the growing demand for effective, natural based allergy products with our strongly valued partner A.Vogel. We think there’s a great strategic fit between A.Vogel’s brand heritage and bitop’s natural cell protector Ectoin®.”, states bitop CEO Wolfgang Hansen.
About Ectoin® containing OTC-products
For more than ten years, bitop has developed and registered medical devices with Ectoin® and out-licensed these patent-protected products in a full-service model to partners all over the world. The natural protection molecule Ectoin® is made in Germany and provides a 100% natural mode of action. bitop offers products with Ectoin® with clinically proven claims in the categories of Cough&Cold, Allergy, Pulmonary Diseases, Ophthalmology, Dermatology and Supportive Cancer Treatment.
For more information on the product range, please contact info@bitop.de or visit www.bitop.de or contact our sales team directly under bd@bitop.de.
To read the full press release, please click here.
*Werkhäuser N, Bilstein A, Sonnemann U. Treatment of allergic rhinitis with ectoine containing nasal spray and eye drops in comparison with azelastine containing nasal spray and eye drops or with cromoglycic Acid containing nasal spray. J Allergy (Cairo). 2014; Epub.
